Skip to main content
OpenTrials
Completed

NCT Number: NCT06185907

In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors

The investigators plan to analyze the data of patients with gastric cancer (GC) consecutively hospitalized in Ruijin Hospital, a large tertiary center in China, comprehensively describe the characteristics of GC patients ≥65 years, and assesse their in-hospital outcomes regarding duration, fee, and death. Factors associated with the in-hospital outcomes will be further comprehensively explored.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ruijin Hospital

Shanghai, 200025, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older gastric cancer (GC) patients
  • With primary malignancies of the stomach (International Classification of Diseases for Oncology, Third Edition [ICD-O-3] topology code: C16)
  • ≥65 years

Exclusion criteria

  • With benign, premalignant, or in situ tumors
  • With cancers originating from non-stomach sites

Treatment and study plan

SURGERY

Other

We referr to resection as that performed in our hospital, and history of major abdominal surgery as interventional surgical procedures in the abdomen with therapeutic intent (e.g., resection) prior to the first hospitalization in our hospital.

Primary outcomes

  1. Mortality

    Time frame: Up to 1 month

    Mortality during first and all hospitalizations

  2. Cost

    Time frame: Up to 1 month

    Costs during first and all hospitalizations

  3. Duration of stay

    Time frame: Up to 1 month

    Duration of stay during first and all hospitalizations

Sponsors and collaborators

Lead sponsor

Ruijin Hospital

Other

Registry information

Official study title

In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors: Large Comprehensive Institution-based Study

Acronym: GGC-01

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Dec 29, 2023
Registry last updated
Dec 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.